AI assistant
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016
Apr 20, 2016
10216_dirs_2016-04-20_7c33b1de-bc9f-49dd-b207-db2515b61ee6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-04-18
Reporting Person: Gerst Diane G. (EVP, QA & Regulatory Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-18 | Common Stock | M | 8210 | $10.48 | Acquired | 39713 | Direct |
| 2016-04-18 | Common Stock | M | 6000 | $11.41 | Acquired | 45713 | Direct |
| 2016-04-18 | Common Stock | S | 15637 | $12.8317 | Disposed | 30076 | Direct |
| 2016-04-19 | Common Stock | M | 5607 | $10.48 | Acquired | 35683 | Direct |
| 2016-04-19 | Common Stock | S | 5607 | $13.0417 | Disposed | 30076 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-18 | Employee Stock Option (right to buy) | $11.41 | M | 6000 | Disposed | 2021-03-08 | Common Stock (6000) | Direct |
| 2016-04-18 | Employee Stock Option (right to buy) | $10.48 | M | 8210 | Disposed | 2022-11-07 | Common Stock (8210) | Direct |
| 2016-04-19 | Employee Stock Option (right to buy) | $10.48 | M | 5607 | Disposed | 2022-11-07 | Common Stock (5607) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $12.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.91 to $13.13, inclusive.
F4: Shares subject to the option vest in five equal annual installments beginning on March 8, 2012.
F5: Shares subject to the option vest in four equal annual installments beginning on November 7, 2013.